1-4 of 4
Denise Hilfiker-Kleiner
Close
Sort by
Journal Articles

Venetoclax and dexamethasone synergize with inotuzumab ozogamicin–induced DNA damage signaling in B-lineage ALL

Brief Report
Hanna Kirchhoff, Uemran Karsli, Caroline Schoenherr, Karin Battmer, Sergej Erschow, Steven R. Talbot, Doris Steinemann, Michael Heuser, Olaf Heidenreich, Denise Hilfiker-Kleiner, Arnold Ganser, Matthias Eder, Michaela Scherr
Journal: Blood
Blood (2021) 137 (19): 2657–2661.
https://doi.org/10.1182/blood.2020008544
Published: 2021
Includes: Supplemental data
Journal Articles

Optimized Induction of Mitochondrial Apoptosis By Combination Therapies with Venetoclax for Chemotherapy-Free Treatment of BCR-ABL + Acute Lymphoblastic Leukemia in Preclinical Models

Matthias Eder, MD, Hanna Kirchhoff, Karin Battmer, Katharina Wohlan, Melanie Ricke-Hoch, PhD, Sergej Erschow, Edward Law, PhD, Arnold Kloos, Michael Heuser, MD, Arnold Ganser, MD, Denise Hilfiker-Kleiner, PhD, Olaf Heidenreich, PhD, Michaela Scherr, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4025.
https://doi.org/10.1182/blood-2018-99-114463
Published: 2018
Journal Articles

Stable Silencing of RUNX1/ETO Induces Expression of a Shortened PU.1 Variant in t(8;21) Kasumi Cells

Matthias Eder, Caroline Schoenherr, Katharina Wohlan, Fabian Frömling, Denise Hilfiker-Kleiner, Arnold Ganser, MD, Michaela Scherr
Journal: Blood
Blood (2016) 128 (22): 2716.
https://doi.org/10.1182/blood.V128.22.2716.2716
Published: 2016
Journal Articles

Mir∼17-92 Identifies BCL2 As a Therapeutic Target In BCR-ABL Positive B-Lineage Acute Lymphoblastic Leukemia

Matthias Eder, MD, Alex Elder, David Barzan, Karin Battmer, Simon Bomken, Melanie Ricke-Hoch, Anke Schröder, Letizia Venturini, Heike Pfeiffer, Helen J Blair, PhD, Josef Vormoor, MD, Oliver G. Ottmann, MD, Arnold Ganser, Andreas Pich, Denise Hilfiker-Kleiner, Olaf Heidenreich, PhD, Michaela Scherr
Journal: Blood
Blood (2013) 122 (21): 835.
https://doi.org/10.1182/blood.V122.21.835.835
Published: 2013